213 related articles for article (PubMed ID: 31332819)
1. Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection.
Tamraz B; Reisner L; French AL; King ST; Fischl MA; Ofotokun I; Kashuba A; Milam J; Murphy K; Augenbraun M; Liu C; Finley PR; Aouizerat B; Cocohoba J; Gange S; Bacchetti P; Greenblatt RM
Pharmacotherapy; 2019 Sep; 39(9):899-911. PubMed ID: 31332819
[TBL] [Abstract][Full Text] [Related]
2. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
3. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
4. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
5. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.
Wada N; Jacobson LP; Cohen M; French A; Phair J; Muñoz A
Am J Epidemiol; 2013 Jan; 177(2):116-25. PubMed ID: 23287403
[TBL] [Abstract][Full Text] [Related]
6. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
[TBL] [Abstract][Full Text] [Related]
7. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.
Cohen MH; French AL; Benning L; Kovacs A; Anastos K; Young M; Minkoff H; Hessol NA
Am J Med; 2002 Aug; 113(2):91-8. PubMed ID: 12133746
[TBL] [Abstract][Full Text] [Related]
8. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
9. [Mortality of HIV infected clients treated with methadone maintenance treatment in Yili Kazakh autonomous prefecture].
Liu EW; Wang SJ; Liu Y; Liu W; Chen ZS; Li XY; A LY; Wu ZY
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Nov; 45(11):979-84. PubMed ID: 22336271
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
[TBL] [Abstract][Full Text] [Related]
11. QTc prolongation in human immunodeficiency virus-infected persons.
Petrosillo N; Lisena FP; Chinello P
Arch Intern Med; 2006 Nov; 166(20):2288-9; author reply 2289-90. PubMed ID: 17101952
[No Abstract] [Full Text] [Related]
12. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.
Vlahov D; Graham N; Hoover D; Flynn C; Bartlett JG; Margolick JB; Lyles CM; Nelson KE; Smith D; Holmberg S; Farzadegan H
JAMA; 1998 Jan; 279(1):35-40. PubMed ID: 9424041
[TBL] [Abstract][Full Text] [Related]
13. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group.
Hessol NA; Anastos K; Levine AM; Ameli N; Cohen M; Young M; Augenbraun M; Miotti P; Gange SJ
AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1105-11. PubMed ID: 10954885
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
17. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women.
Todd JV; Cole SR; Pence BW; Lesko CR; Bacchetti P; Cohen MH; Feaster DJ; Gange S; Griswold ME; Mack W; Rubtsova A; Wang C; Weedon J; Anastos K; Adimora AA
Am J Epidemiol; 2017 May; 185(10):869-878. PubMed ID: 28430844
[TBL] [Abstract][Full Text] [Related]
18. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.
Jiang H; Xie N; Cao B; Tan L; Fan Y; Zhang F; Yao Z; Liu L; Nie S
PLoS One; 2013; 8(12):e83078. PubMed ID: 24376638
[TBL] [Abstract][Full Text] [Related]
19. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs.
Ogunmola OJ; Oladosu YO; Olamoyegun MA
Ann Afr Med; 2015; 14(4):169-76. PubMed ID: 26470741
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of the QTc interval in HIV-infected individuals compared to the general population.
Reinsch N; Arendt M; Geisel MH; Schulze C; Holzendorf V; Warnke A; Neumann T; Brockmeyer NH; Schadendorf D; Eisele L; Erbel R; Moebus S; Jöckel KH; Esser S;
Infection; 2017 Oct; 45(5):659-667. PubMed ID: 28776165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
